Translation. Region: Russian Federation –
Source: Peter the Great St. Petersburg Polytechnic University –
An important disclaimer is at the bottom of this article.
The final round of the "Innovative Solutions for Oncology" case championship, organized by the CHEMRAR Entrepreneurs' Club and the Senezh Management Center, took place in Moscow.
At the championship, teams tackled a pressing problem: developing an AI tool to automate the planning of bioequivalence studies—a key step in the registration of generic drugs. Participants were tasked with creating a prototype system capable of optimizing study design, calculating sample size, generating protocol synopses, and ensuring compliance with regulatory requirements.
SPbPU was represented by Zakhar Vcherashny, a fourth-year student at the Higher School of Automation and Robotics at IMMiT. His team developed a prototype of the Ipharma AI AI system, which automates the design of bioequivalence studies, reduces the workload of specialists, and accelerates documentation preparation. The solution included integration with pharmacokinetic databases (PubMed, DrugBank), sample calculation taking into account intra-subject variability, and the generation of a structured synopsis in LaTeX/Word format.
During the final stage, the team participated in a poster session, presenting key technical and methodological aspects of their solution to experts and colleagues. Participants gained valuable experience interacting with the professional community, exchanged ideas, and discussed the prospects for implementing artificial intelligence in the pharmaceutical industry.
"Participating in the case championship was a unique opportunity to apply theoretical knowledge in practice and work on a real-world problem relevant to the pharmaceutical industry. "We were able to demonstrate how modern technologies can optimize routine processes and impact the quality of research," Zakhar Vcherashny shared his impressions.
The team's project exemplifies an interdisciplinary approach, combining expertise in biostatistics, pharmacology, and machine learning. Participation in the championship allowed the students to expand their professional networks and gain experience working on innovative healthcare solutions.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.